Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Jullien

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Therapie|September 23, 2006
[Pharmacokinetics-pharmacodynamics of antifungal drugs. Consequences for therapeutic drug monitoring]Vincent Jullien, Olivier Lortholary
Clinical Pharmacokinetics|March 14, 2008
Facilitation of drug evaluation in children by population methods and modellingMichel Tod, Vincent Jullien, Gérard Pons
Pharmaceutical Research|June 2, 2021
Conditional Non-parametric Bootstrap for Non-linear Mixed Effect ModelsEmmanuelle Comets, Christelle Rodrigues, Vincent Jullien, et al.
Pharmaceutical Research|February 7, 2008
A physiological model to evaluate drug kinetics in patients with hemorrhagic shock followed by fluid resuscitation. Application to amoxicillin-clavulanateMichel Tod, Franck Lagneau, Vincent Jullien, et al.
Clinical Pharmacokinetics|September 12, 2008
Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patientsBenoit Blanchet, Vincent Jullien, Christophe Vinsonneau, et al.
Hypertension (Dallas, Tex. : 1979)|June 28, 2017
Detecting Nonadherence to Antihypertensive Treatment: Any Time, Anywhere?Idir Hamdidouche, Vincent Jullien, Stéphane Laurent, et al.
Current HIV Research|January 4, 2012
HIV drug resistance on HAART despite an undetectable viral loadPierre Loulergue, Constance Delaugerre, Vincent Jullien, et al.
European Journal of Pharmacology|May 14, 2003
S-15176 inhibits mitochondrial permeability transition via a mechanism independent of its antioxidant propertiesAziz Elimadi, Vincent Jullien, Jean Paul Tillement, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 30, 2003
Determination of tenofovir in human plasma by high-performance liquid chromatography with spectrofluorimetric detectionVincent Jullien, Jean-Marc Tréluyer, Gérard Pons, et al.
The Journal of Antimicrobial Chemotherapy|March 25, 2016
Rifabutin: where do we stand in 2016?Yoann Crabol, Emilie Catherinot, Nicolas Veziris, et al.
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Therapie|September 23, 2006
[Pharmacokinetics-pharmacodynamics of antifungal drugs. Consequences for therapeutic drug monitoring]Vincent Jullien, Olivier Lortholary
Clinical Pharmacokinetics|March 14, 2008
Facilitation of drug evaluation in children by population methods and modellingMichel Tod, Vincent Jullien, Gérard Pons
Pharmaceutical Research|June 2, 2021
Conditional Non-parametric Bootstrap for Non-linear Mixed Effect ModelsEmmanuelle Comets, Christelle Rodrigues, Vincent Jullien, et al.
Pharmaceutical Research|February 7, 2008
A physiological model to evaluate drug kinetics in patients with hemorrhagic shock followed by fluid resuscitation. Application to amoxicillin-clavulanateMichel Tod, Franck Lagneau, Vincent Jullien, et al.
Clinical Pharmacokinetics|September 12, 2008
Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patientsBenoit Blanchet, Vincent Jullien, Christophe Vinsonneau, et al.
Hypertension (Dallas, Tex. : 1979)|June 28, 2017
Detecting Nonadherence to Antihypertensive Treatment: Any Time, Anywhere?Idir Hamdidouche, Vincent Jullien, Stéphane Laurent, et al.
Current HIV Research|January 4, 2012
HIV drug resistance on HAART despite an undetectable viral loadPierre Loulergue, Constance Delaugerre, Vincent Jullien, et al.
European Journal of Pharmacology|May 14, 2003
S-15176 inhibits mitochondrial permeability transition via a mechanism independent of its antioxidant propertiesAziz Elimadi, Vincent Jullien, Jean Paul Tillement, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 30, 2003
Determination of tenofovir in human plasma by high-performance liquid chromatography with spectrofluorimetric detectionVincent Jullien, Jean-Marc Tréluyer, Gérard Pons, et al.
The Journal of Antimicrobial Chemotherapy|March 25, 2016
Rifabutin: where do we stand in 2016?Yoann Crabol, Emilie Catherinot, Nicolas Veziris, et al.
Pageof 13